search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Supported by


AWARDS ENTERPRISE WITHIN PHARMACY BANNSIDE PHARMACY, PORTGLENONE E


very community pharmacist is well aware of the problems caused by the increasing


prevalence of Type 2 diabetes. At present, the condition absorbs ten per cent of the NHS budget in the UK, with an approximate cost of £1 million per day in Northern Ireland.


Type 2 diabetes is a preventable, reversible condition caused primarily by an increase in insulin resistance as a result of poor lifestyle choices. Poor control leads to heart disease, stroke, blindness, kidney disease, nerve damage and amputations leading to disability and premature mortality.


In February 2018, bannside Pharmacy received £2,161.00 funding from the Diabetes UK NI Innovation & Improvement Fund to run a twelve- week programme for ten people with Type 2 diabetes with the aim of helping them achieve better control and/or reversal of their condition. This would involve participants making changes in what they ate and drank, their physical activity levels and management of their stress levels.


bannside Pharmacy Pharmacists Eoghan O'brien and Ryan Graham delivered the programme in partnership with Dr Rebecca Houghton, Consultant Clinical Psychologist – Lead for Clinical Health Psychology, NHSCT, Nora O’Neill, Community Development Worker, Portglenone Enterprise Group and Leslie McLaughlin - Everybody Active 2020 physical activity coach at Mid & East Antrim Council.


Participants were recruited through distribution of A5 flyers and posters, which were shared with the diabetic nurses at health centres in a ten-mile radius, posting on bannside Pharmacy’s Facebook page, and through conversations with some of the pharmacy’s Type 2 patients when


they were in the pharmacy to collect prescriptions.


by the twelve-week mark, the pharmacy hoped to achieve at least one of the following objectives: 1. A decrease in HbA1c to 6.5 per cent (48 mmol/mol) or lower


2. A ten per cent decrease in weight and/or waist measurement


3. An improvement in fitness levels 4. A reduction in the required dose of medicines required for hyperglycaemia as determined by the patient’s diabetic nurse or GP


5. An improvement in a validated measure of psychological health


At weeks 1, 12 and 24 Eoghan and Ryan took the following measurements: Eureka Platform eCare: Weight, bMI, blood Pressure, waist; HbA1c and measurements of Emotional Wellbeing - the Warwick- Edinburgh Mental Well-being Scale (WEMWbS).


A follow-up was completed at 24 weeks as the pharmacists wanted to measure how sustainable the positive changes at twelve weeks had been. The results at the 24-week follow-up were excellent: • Six of the ten participants had a decrease in HbA1c to 6.5 per cent (48 mmol/mol) or lower


• Seven of the ten had a clinically significant decrease in HbA1c by at least 0.5 per cent mmol/L


• Of these two are now in remission


✓ One newly diagnosed (HbA1c from 53 to 42 mmol/mol)


✓ One only on gliclazide – stopped in October by diabetic nurse


• Two of the participants have reduced their medication on the advice of their diabetic nurse. One of these had been ready to start insulin, but his HbA1c has now decreased from 65 to 43.


In addition to the physical results, a follow-up measurement of


John Laverty, Regional Manager North, Alliance Healthcare presents the award to Ryan Graham (left) and Eoghan O'Brien from Bannside Pharmacy


‘This cost-saving programme, with some refinement, has the potential to become an enhanced pharmacy service and resonates with the following recent guidance documents recommending community pharmacy as a suitable port of call for health promotion and diabetes care’


psychological wellbeing at twelve weeks suggested that 78 per cent of participants reported higher levels of psychological wellbeing of three plus points, which is suggestive of meaningful improvement in those participants’ psychological wellbeing.


The positive results have generated considerable goodwill with the participants, who have also spoken positively to others about the health benefits they have received from bannside Pharmacy’s guidance. This has resulted in new customers coming into the pharmacy for lifestyle advice including nutrition, which has also generated more income from OTC sales. This initiative evidences that a community pharmacy-based


programme can be successful in guiding people with Type 2 diabetes – provided they are prepared to make positive changes to their lifestyle - towards better control of their blood glucose levels. by sustaining this, the long-term complications are reduced and the condition can start to be reversed, even to the point of remission.


‘This cost-saving programme,’ says pharmacist Eoghan O’brien, ‘with some refinement, has the potential to become an enhanced pharmacy service and resonates with the following recent guidance documents recommending community pharmacy as a suitable port of call for health promotion and diabetes care.’


PHARMACY IN FOCUS - 37


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48